HDAC9 and neuroblastoma: Indeed, the HDAC inhibitor entinostat was recently shown to increase neuroblastoma immunogenicity in vitro, resulting in increased T and NK cell cytotoxicity, accompanied by an adrenergic-to-mesenchymal cell lineage shift (98).